Latest Breaking News On - Gaston picchio - Page 1 : comparemela.com

Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023

Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its.

Arbutus Biopharma, EyePoint Pharmaceuticals announce key executive hires

Arbutus Biopharma has promoted Karen Sims to chief medical officer and EyePoint Pharmaceuticals appointed Jay Duker as CEO.

Arbutus Completes Enrollment in its Phase 2a Clinical Trial Combining AB-729 with NA Therapy and Peginterferon alfa-2a in Patients with Chronic Hepatitis B Virus Infection

Arbutus Announces Three Poster Presentations with Clinical Data from AB-729 and Preclinical Data from AB-101 at AASLD - The Liver Meeting® 2022

Conference Call and Webcast to discuss the new data being presented at AASLD scheduled for 8:45 AM ET, Friday, November 4, 2022

Arbutus to Present at Chardan's 6th Annual Genetic Medicines Conference